Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.71 |
| ▸ | CA1 | P00915 | 1/20 | 0.71 |
| ▸ | CA2 | P00918 | 1/20 | 0.71 |
| ▸ | CA4 | P22748 | 1/20 | 0.71 |
| ▸ | JUN | P05412 | 1/20 | 0.68 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | BCHE | P06276 | 1/20 | 0.59 |
| ▸ | GUSB | P08236 | 1/20 | 0.59 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.54 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | CDK4 | P11802 | 1/20 | 0.52 |
| ▸ | CCND1 | P24385 | 1/20 | 0.52 |
| ▸ | ALPL | P05186 | 1/20 | 0.51 |
| ▸ | ALPI | P09923 | 1/20 | 0.51 |
| ▸ | ALPG | P10696 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2936064 | 1.00 | NFKB1 (0.71) | NFKB1CA1CA2CA4JUN | |
| SCHEMBL2936063 | 1.00 | NFKB1 (0.71) | NFKB1CA1CA2CA4JUN | |
| SCHEMBL27781270 | 0.86 | NFKB1 (0.70) | NFKB1CA1CA2CA4JUN | |
| SCHEMBL12189733 | 0.85 | IAPP (0.66) | NFKB1CA1CA2CA4JUN | |
| SCHEMBL7591687 | 0.84 | NFKB1 (0.61) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL29353381 | 0.83 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL64886 | 0.83 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL29367602 | 0.83 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL64885 | 0.83 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL892006 | 0.83 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260009056-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | ZYMOCHEM INC (US) | 2026-01-08 | — | — | US | disclosed |
| US-20250185669-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2025-06-12 | — | — | US | disclosed |
| US-12258610-B2 | Production of chemicals from renewable sources | ZYMOCHEM, INC. (US) | 2025-03-25 | — | — | US | disclosed |
| US-12232498-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2025-02-25 | — | — | US | disclosed |
| US-20240172762-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2024-05-30 | — | — | US | disclosed |
| US-11980192-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2024-05-14 | — | — | US | disclosed |
| US-20240016160-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2024-01-18 | — | — | US | disclosed |
| US-11832616-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2023-12-05 | — | — | US | disclosed |
| US-11832617-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2023-12-05 | — | — | US | disclosed |
| US-20230270118-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2023-08-31 | — | — | US | disclosed |
| US-20080090277-A1 | NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PRODUCTION OF CRYPTOPHYCIN | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-04-17 | — | — | US | disclosed |
| EP-1751279-A4 | NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PRODUCTION OF CRYPTOPHYCIN | UNIV MINNESOTA (US) | 2008-03-19 | — | — | EP | disclosed |
| US-20080050796-A1 | Nucleic Acids and Polypeptides Involved in the Production of Cryptophycin | REGENTS OF THE UNIVERSITY OF MINNESOTA, A MINNESOTA CORPORATION | 2008-02-28 | — | — | US | disclosed |
| US-7229814-B2 | Nucleic acids and polypeptides involved in the production of cryptophycin | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2007-06-12 | — | — | US | disclosed |
| EP-1751279-A2 | NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PRODUCTION OF CRYPTOPHYCIN | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2007-02-14 | — | — | EP | disclosed |
| US-20060095982-A1 | Phytoremediation of contaminant compounds via chloroplast genetic engineering | UNIVERSITY OF CENTRAL FLORIDA (US) | 2006-05-04 | — | — | US | disclosed |
| US-20060057698-A1 | Nucleic acids and polypeptides involved in the production of cryptophycin | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-03-16 | — | — | US | disclosed |
| WO-2005116200-A2 | NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PRODUCTION OF CRYPTOPHYCIN | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2005-12-08 | — | — | WO | disclosed |
| US-20030215859-A1 | DNA shuffling of monooxygenase genes for production of industrial chemicals | MAXYGEN, INC. | 2003-11-20 | — | — | US | disclosed |
| US-6605430-B1 | Genetic engineering to produce library of polynucleotides encoding polypeptides; screening, recovering | MAXYGEN, INC. | 2003-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009056-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | HPD, PGD, ADSL | NFKB1 3307/4885CA1 4418/4885CA2 3901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.